Thursday, September 29, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NeuralCIM

Havana, Jul 6 (Prensa Latina) Studies related to the use of neuroprotective drug NeuralCIM (NeuroEPO) continue in Cuba´s capital by staring off consultations for the classification of patients who will be part of the phase III clinical trial.